Actualités Benitec Biopharma Limited - BLT | Actions Australian Stock Exchange

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

BHP Sees Development Options to Lift Petroleum Output

By Robb M. Stewart MELBOURNE, Australia--BHP Group Ltd. (BHP.AU) has flagged a number of projects that could boost its oil production and help the...

ADRs End Slightly Higher; Santander, Embraer Actively

International stocks trading in New York closed slightly higher on Thursday. The BNY Mellon index of American depositary receipts rose 0.7% to...

Benitec Establishes A Sponsored US ADR Program

Benitec Establishes A Sponsored US ADR Program PR Newswire SYDNEY, May 30, 2014 SYDNEY, May 30, 2014 /PRNewswire/ -- Benitec Biopharma Limited...

Benitec Commences Patient Dosing With TT-034 In Patients With Hepatitis C

Benitec Commences Patient Dosing With TT-034 In Patients With Hepatitis C PR Newswire SYDNEY, May 29, 2014 SYDNEY, May 29, 2014 /PRNewswire/...

Dernières informations sur les brevets européens

Dernières informations sur les brevets européens PR Newswire LA HAYE, Pays-Bas, 23 mai 2014 -- Issue de l'audience d'opposition devant l'OEB...

European Patents Update

European Patents Update PR Newswire THE HAGUE, The Netherlands, May 22, 2014 -- Outcome of EPO opposition hearing -- Benitec executes license...

European Patents Update

European Patents Update -- Outcome of EPO opposition hearing -- Benitec executes license from Galapagos NV for RNAi in Europe PR Newswire THE...

Benitec Biopharma Completes AUD $31.5 million Private Placement

Benitec Biopharma Completes AUD $31.5 million Private Placement Shareholders Overwhelmingly Approve Second AUD $15.7 million Tranche Following...

Benitec Biopharma Announces Private Placement of Ordinary Shares and Warrants

Benitec Biopharma Announces Private Placement of Ordinary Shares and Warrants Company to Receive up to approximately AUD $31.5 million to...

HCV clinical trial application submitted to Recombinant DNA Advisory Committee (RAC)

HCV clinical trial application submitted to Recombinant DNA Advisory Committee (RAC) -- Benitec progresses hepatitis C therapeutic towards the...

Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepati...

Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepatitis C Infections PR...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Benitec Biopharma Limited (BLT)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Benitec Biopharma Limited (BLT) Actualités

BHP Sees Development Options to Lift Petroleum Output

ADRs End Slightly Higher; Santander, Embraer Actively

Benitec Establishes A Sponsored US ADR Program

Benitec Commences Patient Dosing With TT-034 In Patients With Hepatitis C

Dernières informations sur les brevets européens

European Patents Update

European Patents Update

Benitec Biopharma Completes AUD $31.5 million Private Placement

Benitec Biopharma Announces Private Placement of Ordinary Shares and Warrants

HCV clinical trial application submitted to Recombinant DNA Advisory Committee (RAC)

Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepati...

Appointment of Mr. Kevin Buchi to Benitec Board

Benitec Selects the Duke Clinical Research Unit as a Site for Hepatitis C Phase I/II Clinical Trial

uniQure Licenses RNA Interference Technology to Advance Huntington's Disease Program

Benitec Raises AU$8 million to Forge Ahead with its Gene Silencing Therapeutics: Rights Issue Closes Oversubscribed

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Benitec Biopharma Limited (BLT)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Benitec Biopharma Limited (BLT) Actualités

BHP Sees Development Options to Lift Petroleum Output

ADRs End Slightly Higher; Santander, Embraer Actively

Benitec Establishes A Sponsored US ADR Program

Benitec Commences Patient Dosing With TT-034 In Patients With Hepatitis C

Dernières informations sur les brevets européens

European Patents Update

European Patents Update

Benitec Biopharma Completes AUD $31.5 million Private Placement

Benitec Biopharma Announces Private Placement of Ordinary Shares and Warrants

HCV clinical trial application submitted to Recombinant DNA Advisory Committee (RAC)

Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepati...

Appointment of Mr. Kevin Buchi to Benitec Board

Benitec Selects the Duke Clinical Research Unit as a Site for Hepatitis C Phase I/II Clinical Trial

uniQure Licenses RNA Interference Technology to Advance Huntington's Disease Program

Benitec Raises AU$8 million to Forge Ahead with its Gene Silencing Therapeutics: Rights Issue Closes Oversubscribed

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités